Blog - Pear VC

Sell the outcome, not the AI tool: Why Pear is betting on AI-Native Services
Read More: Sell the outcome, not the AI tool: Why Pear is betting on AI-Native Services

Minimum Fundable Team: how early team shapes seed fundraising
PearX: join the ranks of elite founders
Pear Biotech Bench to Business: insights on tackling solid tumors and navigating company creation with Shelley Force Aldred
Pear portfolio company BioAge Labs announces oversubscribed $170M Series D financing
Pear Biotech Bench to Business: insights on the past, present, and future of synthetic biology with Dr. Jim Collins
Perspectives in AI with Kamil Rocki, Head of Performance Engineering at Stability AI
Looking back at PearX S19 alum Gradio’s journey, now part of Hugging Face
Pear Biotech Bench to Business: insights on generative AI in healthcare and biotech with Dr. James Zou
Introducing Pear’s Healthcare and Biotech Industry Advisory Councils!
PearX S19 alum Polimorphic raises $5.6M to continue their work building a constituent relationship management platform for governments
The vertical software data gold mine
PearX S20 alumni company Sequel receives FDA approval